Previous 10 | Next 10 |
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Syneos To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - September 22, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm,...
The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Syneos Health, Inc. (“Syneos”) ( NASDAQ: SYNH ). The action charges Syneos with violations of the federal securities la...
MORRISVILLE, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic collaboration that will expand its relationship with Oracle. Using the Oracle Cerner Learning Health Netwo...
2023-09-06 12:35:03 ET More on Syneos Health Seeking Alpha’s Quant Rating on Syneos Health Historical earnings data for Syneos Health Financial information for Syneos Health Syneos Health: Pre-Vote Checks, Trading At 1.7% Discount To PE Offer F...
MORRISVILLE, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Star Parent, Inc. (the “ Issuer ” or the “ Company ”) and Syneos Health, Inc. (“ Syneos Health ”), announced today that, subject to market conditions and other factors, the Issuer intends t...
2023-08-24 17:32:59 ET Summary Horizon Therapeutics remains the top stock held by merger-focused funds for the third consecutive quarter. Activision Blizzard is consistently in the top two positions among these funds for the fifth straight quarter. Some funds have oversized po...
RADNOR, PA / ACCESSWIRE / August 18, 2023 / The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been against Syneos Health, Inc. ("Syneos") (NASDAQ:SYNH) . The action charges Syneos with violations of the federal ...
NEW YORK, NY / ACCESSWIRE / August 8, 2023 / Levi & Korsinsky, LLP notifies investors in Syneos Health, Inc. ("Syneos" or the "Company") (NASDAQ:SYNH) of a class action securities lawsuit. The lawsuit on behalf of Syneos investors has been commenced in the United States District Court for...
MORRISVILLE, N.C., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organization, today announced that the Company’s stockholders approved an agreement...
2023-07-22 05:30:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Economic resiliency, s...
News, Short Squeeze, Breakout and More Instantly...
Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S. PR Newswire JERSEY CITY, N.J. , April 29, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) is celebrating its eight-year anniversary of being established in th...
Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting PR Newswire Presentations span Parkinson's disease and ALS clinical and real-world evidence Oral platform sessions will highlight r...
Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS® (edaravone) PR Newswire Orphan Drug Exclusivity recognized for RADICAVA ORS based on major contribution to patient care JERSEY CITY, N.J. ...